Shopping Cart 0
Cart Subtotal
AED 0

Global Wound Care Biologics Market_Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 15414

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 19818
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Global wound care biologics market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases aging population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for global wound care biologics s market are listed below:

Smith and Nephew

INTEGRA LIFE SCIENCES CORPORATION

Molnlycke Health Care AB

Amnio Technology, LLC

Alphatec Spine, Inc.

BioHorizons IPH, Inc.

ORGANOGENESIS INC

CONVATEC AG

Skye Biologics Inc.

Anika Therapeutics, Inc.

Osiris Therapeutics, Inc.

Vericel Corporation

MiMedx

WRIGHT MEDICAL GROUP N.V.

Kerecis

ACell Inc.

Solsys Medical

Marine Polymer Technologies, Inc.

Amniox Medical, Inc.

Amniox Medical, Inc.

The global wound care biologics market is segmented into:

Product Type

Wound Type

End User

On the basis of product type the global wound care biologics market is segmented into synthetic skin grafts, growth factors, allografts, xenografts. In 2018, synthetic skin grafts segment is expected to dominate the Global wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF)segment, platelet rich plasma (PRP)segment, epidermal growth factor (EGF)segment and basic fibroblast growth factor (BFGF)segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa, thrombin peptide (TP508)segment, keratinocyte growth factor (KGF)segment.

On the basis of wound type the global wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segmentis expected to dominate the global wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.

On the basis of end user the global wound care biologics s market is segmented into hospitals, wound care centres and ambulatory centers, clinics, community healthcare centers. In 2018, hospitals are expected to dominate the global wound care biologics market with the highest market shares in the forecast period 2018 to 2025.

Based on geography, the market is segmented into 5 geographical regions:

Europe

North America

Asia-Pacific

South America

Middle East & Africa

Covered in this report

The report covers the present scenario and the growth prospects of the global wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Table Of Content

Scope

Table Of Contents

1 Introduction 31

1.1 Objectives Of The Study 31

1.2 Market Definition 31

1.3 Overview Of Global Wound Care Biologics Market 31

1.4 Currency And Pricing 32

1.5 Limitation 32

1.6 Markets Covered 33

2 Market Segmentation 35

2.1 Markets Covered 35

2.2 Geographic Scope 36

2.3 Years Considered For The Study 37

2.4 Currency And Pricing 37

2.5 Research Methodology 38

2.6 Primary Interviews With Key Opinion Leaders 41

2.1 Dbmr Market Position Grid 42

2.2 Dbmr Market Challenge Matrix 43

2.3 Secondary Sources 44

2.4 Assumptions 44

3 Market Overview 45

3.1 Drivers 47

3.1.1 Increasing Cases Of Diabetic Foot Ulcers 47

3.1.2 Increasing Incidences Of Burn Cases 47

3.1.3 Rising Number Of Geriatric Population 48

3.1.4 Innovation In Wound Care Biologics 49

3.1.5 New Product Launches 51

3.2 Restrains 51

3.2.1 High Cost Of Wound Treatment And Wound Care Biologics 51

3.2.2 Risk Of Skin Substitue Failure 52

3.3 Opportunities 53

3.3.1 3D Skin Printing 53

3.3.2 Awareness Programs 54

3.4 Challenges 55

3.4.1 Lack Of Wound Management Services 55

4 Executive Summary 56

5 Premium Insights 60

6 Global Wound Care Biologics Market, By Product Type 65

6.1 Overview 66

6.2 Synthetic Skin Grafts 68

6.3 Growth Factors 69

6.3.1 Platelet Derived Growth Factor (Pdgf) 72

6.3.2 Platelet Rich Plasma (Prp) 72

6.3.3 Epidermal Growth Factors (Egf) 72

6.3.4 Basic Fibroblast Growth Factors (Bfgf) 73

6.3.5 Granulocyte Colony Stimulating Factor (G-Csf) 73

6.3.6 Talactoferrin Alfa 73

6.3.7 Thrombin Peptide 74

6.3.8 Keratinocy Growth Factor (Kgf) 74

6.4 Allografts 75

6.5 Xenografts 76

7 Global Wound Care Biologics Market, By Wound Type 78

7.1 Overview 79

7.2 Wounds 80

7.2.1 Surgical Wound 82

7.2.1.1 Skin Surgery 83

7.2.1.1.1 Wound Closure 84

7.2.1.1.2 Skin Biopsy 84

7.2.1.1.3 Skin Flap 84

7.2.1.1.4 Skin Graft 84

7.2.1.1.5 Others 84

7.2.1.2 Cosmetic Procedure 85

7.2.1.2.1 Brest Enhancement 86

7.2.1.2.2 Facial Contouring 87

7.2.1.2.3 Facial Rejuvenation: 87

7.2.1.2.4 Body Contouring 87

7.2.1.2.5 Skin Rejuvenation 87

7.2.1.2.6 Others 88

7.2.1.3 Gynecologic Procedures 88

7.2.1.3.1 Pubovaginalis Sling 88

7.2.1.3.2 Pelvic Floor Reconstruction 89

7.2.1.3.3 Rectocele Repair Surgery 89

7.2.1.3.4 Others 89

7.2.1.4 Gastrointestinal Procedure 89

7.2.1.4.1 General Gastrointestinal Surgery 90

7.2.1.4.2 Hernia 91

7.2.1.4.3 Others 91

7.2.2 Acute Wounds 92

7.2.3 Chronic Wounds 92

7.2.4 Traumatic Wounds 93

7.3 Burns 93

7.3.1 Ulcers 94

7.3.2 Diabetic Ulcers 96

7.3.3 Pressure Ulcer 96

7.3.4 Venous Ulcer 97

7.3.5 Others 97

8 Global Wound Care Biologics Market, By End User 98

8.1 Overview 99

8.2 Hospitals 101

8.3 Wound Care Centers 102

8.4 Ambulatory Surgical Centers 103

8.5 Clinics 105

8.6 Community Healthcare Center 106

9 Global Wound Care Biologics Market: Geography 107

9.1 Global 107

9.2 North America 114

9.2.1 U.S. 125

9.2.2 Canada 132

9.2.3 Mexico 139

9.3 Europe 146

9.3.1 Germany 158

9.3.2 France 165

9.3.3 U.K. 172

9.3.4 Italy 179

9.3.5 Switzerland 186

9.3.6 Netherlands 193

9.3.7 Russia 201

9.3.8 Turkey 208

9.3.9 Spain 215

9.3.10 Belgium 222

9.3.11 Rest Of Europe 229

9.4 Asia-Pacific 230

9.4.1 China 242

9.4.2 Japan 249

9.4.3 India 256

9.4.4 South Korea 263

9.4.5 Australia 270

9.4.6 Thailand 277

9.4.7 Malaysia 284

9.4.8 Singapore 291

9.4.9 Indonesia 298

9.4.10 Philippines 305

9.4.11 Rest Of Asia-Pacific 312

9.5 South America 313

9.5.1 Brazil 324

9.5.2 Rest Of South America 331

9.6 Middle East & Africa 332

9.6.1 South Africa 343

9.6.2 Rest Of Middle East & Africa 350

10 Global Wound Care Biologics Market, Company Landscape 351

10.1 Company Share Analysis: Global 351

10.2 Company Share Analysis: North America 352

10.3 Company Share Analysis: Europe 353

10.4 Company Share Analysis: Asia-Pacific 354

11 Company Profile 355

11.1 Mimedx. 355

11.1.1 Company Overview 355

11.1.2 Revenue Analysis: 355

11.1.3 Company Share Analysis: 356

11.1.4 Product Portfolio 356

11.1.5 Recent Developments 357

11.2 Organogenesis Inc 358

11.2.1 Company Overview 358

11.2.2 Geographic Presence 358

11.2.3 Company Share Analysis: 359

11.2.4 Product Portfolio 359

11.2.5 Recent Developments 360

11.3 Integra Lifesciences 361

11.3.1 Company Overview 361

11.3.2 Revenue Analysis 361

11.3.3 Company Share Analysis: 362

11.3.4 Product Portfolio 362

11.3.5 Recent Developments 363

11.4 Convatec Inc. 364

11.4.1 Company Overview 364

11.4.2 Revenue Analysis 364

11.4.3 Company Share Analysis: 365

11.4.4 Product Portfolio : 365

11.4.5 Recent Developments 365

11.5 Acell Inc. 366

11.5.1 Company Overview 366

11.5.2 Product Portfolio 366

11.5.3 Recent Developments 367

11.6 Allosource 368

11.6.1 Company Overview 368

11.6.2 Product Portfolio 368

11.6.3 Recent Developments 369

11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc) 370

11.7.1 Company Overview 370

11.7.2 Product Portfolio 370

11.7.3 Recent Developments 370

11.8 Amnio Technology, Llc 371

11.8.1 Company Overview 371

11.8.2 Product Portfolio 371

11.8.3 Recent Developments 372

11.9 Amniox Medical, Inc. 373

11.9.1 Company Overview 373

11.9.2 Product Portfolio 373

11.9.3 Recent Developments 374

11.10 Anika Therapeutics, Inc. 375

11.10.1 Company Overview 375

11.10.2 Revenue Analysis 375

11.10.3 Product Portfolio 376

11.10.4 Recent Developments 376

11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.) 377

11.11.1 Company Overview 377

11.11.2 Geographicpresence 377

11.11.3 Product Portfolio 378

11.11.4 Recent Developments 378

11.12 Kerecis 379

11.12.1 Company Overview 379

11.12.2 Geographical Presence 379

11.12.3 Product Portfolio 380

11.12.4 Recent Developments 380

11.13 Marine Polymer Technologies, Inc 381

11.13.1 Company Overview 381

11.13.2 Product Portfolio 381

11.13.3 Recent Developments 381

11.14 Molnlycke Health Care Ab 382

11.14.1 Company Overview 382

11.14.2 Revenue Analysis 382

11.14.3 Product Portfolio 383

11.14.4 Recent Developments 383

11.15 Osiris Therapeutics, Inc. 384

11.15.1 Company Overview 384

11.15.2 Revenue Analysis 384

11.15.3 Product Portfolio 385

11.15.4 Recent Developments 385

11.16 Skye Biologics Inc. 386

11.16.1 Company Overview 386

11.16.2 Product Portfolio : 386

11.16.3 Recent Development: 387

11.17 Smith And Nephew 388

11.17.1 Company Overview 388

11.17.2 Revenue Analysis 388

11.17.3 Product Portfolio 389

11.17.4 Recent Developments 389

11.18 Solsys Medical. 390

11.18.1 Company Overview 390

11.18.2 Product Portfolio 391

11.18.3 Recent Developments 391

11.19 Vericel Corporation. 392

11.19.1 Company Overview 392

11.19.2 1.1.2 Revenue Analysis 392

11.19.3 Product Portfolio 393

11.19.4 Recent Developments 393

11.20 Wright Medical Group N.V 394

11.20.1 Company Overview 394

11.20.2 1.1.2 Revenue Analysis 394

11.20.3 Product Portfolio 395

11.20.4 Recent Developments 396

12 Related Reports 397

?


List Of Figure

List Of Figures

Figure 1 Global Wound Care Biologics Market: Segmentation 35

Figure 2 Global Wound Care Biologics Market: Data Triangulation 38

Figure 3 Global Wound Care Biologics Market: Research Snapshot 39

Figure 4 Global Wound Care Biologics Market: Bottom Up Approach 40

Figure 5 Global Wound Care Biologics Market: Top Down Approach 40

Figure 6 Global Wound Care Biologics Market: Interview Demographics 41

Figure 1 Global Wound Care Biologics Market: Dbmr Market Position Grid 42

Figure 2 Global Wound Care Biologics Market: The Market Challenge Matrix 43

Figure 3 Drivers, Restraints, Opportunities And Challenges Of Global Wound Care Biologics Market 46

Figure 4 Aging Population In Different Countries (2014, 2017 & 2020) 49

Figure 5 Global Wound Care Biologics Market: Segmentation 58

Figure 6 North America Is Anticipated To Dominate The Global Wound Care Biologics Market And Asia Pacific Is Estimated To Be Increasing With The Strong Cagr In The Forecast Period From 2018 To 2025 59

Figure 7 Increasing Prevelance Of Diabetic Foot Ulcers And Increasing Incidences Of Burn Cases Are Expected To Drive The Market For Global Wound Care Biologics In The Forecast Period 2018 To 2025 60

Figure 8 Synthetic Skin Grafts In Global Wound Care Biologics Is Expected To Account For The Largest Share Of The Global Wound Care Biologics Market In 2018 & 2025 61

Figure 9 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Global Wound Care Biologics Market In The Forecast Period From 2018 To 2025 62

Figure 10 Worldwide Prevalence Of Various Wound Types, 2011 63

Figure 11 Cases Of Burn Injuries, (2009-2012) 63

Figure 12 Prevalence Of Pressure Ulcers In Few Countries 64

Figure 13 Number Of Surgical Procedures And Surgical Site Infections 64

Figure 14 Global Wound Care Biologics Market: By Product Type, 2017 66

Figure 15 Global Wound Care Biologics Market: By Wound Type, 2017 79

Figure 16 Global Wound Care Biologics Market: By End User, Snapshot 2017 99

Figure 17 Global Wound Care Biologics Market: Snapshot (2017) 108

Figure 18 Global Wound Care Biologics Market: By Country (2017) 109

Figure 19 Global Wound Care Biologics Market: By Country (2018 & 2025) 110

Figure 20 Global Wound Care Biologics Market, By Country (2017 & 2025) 111

Figure 21 Global Wound Care Biologics Market, By Product Type (2018 -2025) 112

Figure 22 North America Wound Care Biologics Market: Snapshot (2017) 114

Figure 23 North America Wound Care Biologics Market: By Country (2017) 115

Figure 24 North America Wound Care Biologics Market: By Country (2018 & 2025) 115

Figure 25 North America Wound Care Biologics Market, By Country (2017 & 2025) 116

Figure 26 North America Wound Care Biologics Market, By Product Type (2018 -2025) 117

Figure 27 Europe Wound Care Biologics Market: Snapshot (2017) 146

Figure 28 Europe Wound Care Biologics Market: By Country (2017) 147

Figure 29 Europe Wound Care Biologics Market: By Country (2018 & 2025) 148

Figure 30 Europe Wound Care Biologics Market, By Country (2017 & 2025) 149

Figure 31 Europe Wound Care Biologics Market, By Product Type (2018 -2025) 150

Figure 32 Asia-Pacific Wound Care Biologics Market: Snapshot (2017) 230

Figure 33 Asia-Pacific Wound Care Biologics Market: By Country (2017) 231

Figure 34 Asia-Pacific Wound Care Biologics Market: By Country (2018 & 2025) 232

Figure 35 Asia-Pacific Wound Care Biologics Market, By Country (2017 & 2025) 233

Figure 36 Asia-Pacific Wound Care Biologics Market, By Product Type (2018 -2025) 234

Figure 37 South America Wound Care Biologics Market: Snapshot (2017) 313

Figure 38 South America Wound Care Biologics Market: By Country (2017) 314

Figure 39 South America Wound Care Biologics Market: By Country (2018 & 2025) 314

Figure 40 South America Wound Care Biologics Market, By Country (2017 & 2025) 315

Figure 41 South America Wound Care Biologics Market, By Product Type (2018 -2025) 316

Figure 42 Middle East & Africa Wound Care Biologics Market: Snapshot (2017) 332

Figure 43 Middle East & Africa Wound Care Biologics Market: By Country (2017) 333

Figure 44 Middle East & Africa Wound Care Biologics Market: By Country (2018 & 2025) 333

Figure 45 Middle East & Africa Wound Care Biologics Market, By Country (2017 & 2025) 334

Figure 46 Middle East & Africa Wound Care Biologics Market, By Product Type (2018 -2025) 335

Figure 47 Global Wound Care Biologics Market: Company Share 2017 (%) 351

Figure 48 North America Wound Care Biologics Market: Company Share 2017 (%) 352

Figure 49 Europe Wound Care Biologics Market: Company Share 2017 (%) 353

Figure 50 Asia-Pacific Wound Care Biologics Market: Company Share 2017 (%) 354


List Of Table

Too Lengthy To Be Pasted

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

MiMedx

Organogenesis Inc.

Integra LifeSciences

ConvaTec Inc.

Smith and Nephew

INTEGRA LIFE SCIENCES CORPORATION

Molnlycke Health Care AB

Global wound care biologics market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases aging population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for global wound care biologics s market are listed below:

Smith and Nephew

INTEGRA LIFE SCIENCES CORPORATION

Molnlycke Health Care AB

Amnio Technology, LLC

Alphatec Spine, Inc.

BioHorizons IPH, Inc.

ORGANOGENESIS INC

CONVATEC AG

Skye Biologics Inc.

Anika Therapeutics, Inc.

Osiris Therapeutics, Inc.

Vericel Corporation

MiMedx

WRIGHT MEDICAL GROUP N.V.

Kerecis

ACell Inc.

Solsys Medical

Marine Polymer Technologies, Inc.

Amniox Medical, Inc.

Amniox Medical, Inc.

The global wound care biologics market is segmented into:

Product Type

Wound Type

End User

On the basis of product type the global wound care biologics market is segmented into synthetic skin grafts, growth factors, allografts, xenografts. In 2018, synthetic skin grafts segment is expected to dominate the Global wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF)segment, platelet rich plasma (PRP)segment, epidermal growth factor (EGF)segment and basic fibroblast growth factor (BFGF)segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa, thrombin peptide (TP508)segment, keratinocyte growth factor (KGF)segment.

On the basis of wound type the global wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segmentis expected to dominate the global wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.

On the basis of end user the global wound care biologics s market is segmented into hospitals, wound care centres and ambulatory centers, clinics, community healthcare centers. In 2018, hospitals are expected to dominate the global wound care biologics market with the highest market shares in the forecast period 2018 to 2025.

Based on geography, the market is segmented into 5 geographical regions:

Europe

North America

Asia-Pacific

South America

Middle East & Africa

Covered in this report

The report covers the present scenario and the growth prospects of the global wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Scope

Table Of Contents

1 Introduction 31

1.1 Objectives Of The Study 31

1.2 Market Definition 31

1.3 Overview Of Global Wound Care Biologics Market 31

1.4 Currency And Pricing 32

1.5 Limitation 32

1.6 Markets Covered 33

2 Market Segmentation 35

2.1 Markets Covered 35

2.2 Geographic Scope 36

2.3 Years Considered For The Study 37

2.4 Currency And Pricing 37

2.5 Research Methodology 38

2.6 Primary Interviews With Key Opinion Leaders 41

2.1 Dbmr Market Position Grid 42

2.2 Dbmr Market Challenge Matrix 43

2.3 Secondary Sources 44

2.4 Assumptions 44

3 Market Overview 45

3.1 Drivers 47

3.1.1 Increasing Cases Of Diabetic Foot Ulcers 47

3.1.2 Increasing Incidences Of Burn Cases 47

3.1.3 Rising Number Of Geriatric Population 48

3.1.4 Innovation In Wound Care Biologics 49

3.1.5 New Product Launches 51

3.2 Restrains 51

3.2.1 High Cost Of Wound Treatment And Wound Care Biologics 51

3.2.2 Risk Of Skin Substitue Failure 52

3.3 Opportunities 53

3.3.1 3D Skin Printing 53

3.3.2 Awareness Programs 54

3.4 Challenges 55

3.4.1 Lack Of Wound Management Services 55

4 Executive Summary 56

5 Premium Insights 60

6 Global Wound Care Biologics Market, By Product Type 65

6.1 Overview 66

6.2 Synthetic Skin Grafts 68

6.3 Growth Factors 69

6.3.1 Platelet Derived Growth Factor (Pdgf) 72

6.3.2 Platelet Rich Plasma (Prp) 72

6.3.3 Epidermal Growth Factors (Egf) 72

6.3.4 Basic Fibroblast Growth Factors (Bfgf) 73

6.3.5 Granulocyte Colony Stimulating Factor (G-Csf) 73

6.3.6 Talactoferrin Alfa 73

6.3.7 Thrombin Peptide 74

6.3.8 Keratinocy Growth Factor (Kgf) 74

6.4 Allografts 75

6.5 Xenografts 76

7 Global Wound Care Biologics Market, By Wound Type 78

7.1 Overview 79

7.2 Wounds 80

7.2.1 Surgical Wound 82

7.2.1.1 Skin Surgery 83

7.2.1.1.1 Wound Closure 84

7.2.1.1.2 Skin Biopsy 84

7.2.1.1.3 Skin Flap 84

7.2.1.1.4 Skin Graft 84

7.2.1.1.5 Others 84

7.2.1.2 Cosmetic Procedure 85

7.2.1.2.1 Brest Enhancement 86

7.2.1.2.2 Facial Contouring 87

7.2.1.2.3 Facial Rejuvenation: 87

7.2.1.2.4 Body Contouring 87

7.2.1.2.5 Skin Rejuvenation 87

7.2.1.2.6 Others 88

7.2.1.3 Gynecologic Procedures 88

7.2.1.3.1 Pubovaginalis Sling 88

7.2.1.3.2 Pelvic Floor Reconstruction 89

7.2.1.3.3 Rectocele Repair Surgery 89

7.2.1.3.4 Others 89

7.2.1.4 Gastrointestinal Procedure 89

7.2.1.4.1 General Gastrointestinal Surgery 90

7.2.1.4.2 Hernia 91

7.2.1.4.3 Others 91

7.2.2 Acute Wounds 92

7.2.3 Chronic Wounds 92

7.2.4 Traumatic Wounds 93

7.3 Burns 93

7.3.1 Ulcers 94

7.3.2 Diabetic Ulcers 96

7.3.3 Pressure Ulcer 96

7.3.4 Venous Ulcer 97

7.3.5 Others 97

8 Global Wound Care Biologics Market, By End User 98

8.1 Overview 99

8.2 Hospitals 101

8.3 Wound Care Centers 102

8.4 Ambulatory Surgical Centers 103

8.5 Clinics 105

8.6 Community Healthcare Center 106

9 Global Wound Care Biologics Market: Geography 107

9.1 Global 107

9.2 North America 114

9.2.1 U.S. 125

9.2.2 Canada 132

9.2.3 Mexico 139

9.3 Europe 146

9.3.1 Germany 158

9.3.2 France 165

9.3.3 U.K. 172

9.3.4 Italy 179

9.3.5 Switzerland 186

9.3.6 Netherlands 193

9.3.7 Russia 201

9.3.8 Turkey 208

9.3.9 Spain 215

9.3.10 Belgium 222

9.3.11 Rest Of Europe 229

9.4 Asia-Pacific 230

9.4.1 China 242

9.4.2 Japan 249

9.4.3 India 256

9.4.4 South Korea 263

9.4.5 Australia 270

9.4.6 Thailand 277

9.4.7 Malaysia 284

9.4.8 Singapore 291

9.4.9 Indonesia 298

9.4.10 Philippines 305

9.4.11 Rest Of Asia-Pacific 312

9.5 South America 313

9.5.1 Brazil 324

9.5.2 Rest Of South America 331

9.6 Middle East & Africa 332

9.6.1 South Africa 343

9.6.2 Rest Of Middle East & Africa 350

10 Global Wound Care Biologics Market, Company Landscape 351

10.1 Company Share Analysis: Global 351

10.2 Company Share Analysis: North America 352

10.3 Company Share Analysis: Europe 353

10.4 Company Share Analysis: Asia-Pacific 354

11 Company Profile 355

11.1 Mimedx. 355

11.1.1 Company Overview 355

11.1.2 Revenue Analysis: 355

11.1.3 Company Share Analysis: 356

11.1.4 Product Portfolio 356

11.1.5 Recent Developments 357

11.2 Organogenesis Inc 358

11.2.1 Company Overview 358

11.2.2 Geographic Presence 358

11.2.3 Company Share Analysis: 359

11.2.4 Product Portfolio 359

11.2.5 Recent Developments 360

11.3 Integra Lifesciences 361

11.3.1 Company Overview 361

11.3.2 Revenue Analysis 361

11.3.3 Company Share Analysis: 362

11.3.4 Product Portfolio 362

11.3.5 Recent Developments 363

11.4 Convatec Inc. 364

11.4.1 Company Overview 364

11.4.2 Revenue Analysis 364

11.4.3 Company Share Analysis: 365

11.4.4 Product Portfolio : 365

11.4.5 Recent Developments 365

11.5 Acell Inc. 366

11.5.1 Company Overview 366

11.5.2 Product Portfolio 366

11.5.3 Recent Developments 367

11.6 Allosource 368

11.6.1 Company Overview 368

11.6.2 Product Portfolio 368

11.6.3 Recent Developments 369

11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc) 370

11.7.1 Company Overview 370

11.7.2 Product Portfolio 370

11.7.3 Recent Developments 370

11.8 Amnio Technology, Llc 371

11.8.1 Company Overview 371

11.8.2 Product Portfolio 371

11.8.3 Recent Developments 372

11.9 Amniox Medical, Inc. 373

11.9.1 Company Overview 373

11.9.2 Product Portfolio 373

11.9.3 Recent Developments 374

11.10 Anika Therapeutics, Inc. 375

11.10.1 Company Overview 375

11.10.2 Revenue Analysis 375

11.10.3 Product Portfolio 376

11.10.4 Recent Developments 376

11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.) 377

11.11.1 Company Overview 377

11.11.2 Geographicpresence 377

11.11.3 Product Portfolio 378

11.11.4 Recent Developments 378

11.12 Kerecis 379

11.12.1 Company Overview 379

11.12.2 Geographical Presence 379

11.12.3 Product Portfolio 380

11.12.4 Recent Developments 380

11.13 Marine Polymer Technologies, Inc 381

11.13.1 Company Overview 381

11.13.2 Product Portfolio 381

11.13.3 Recent Developments 381

11.14 Molnlycke Health Care Ab 382

11.14.1 Company Overview 382

11.14.2 Revenue Analysis 382

11.14.3 Product Portfolio 383

11.14.4 Recent Developments 383

11.15 Osiris Therapeutics, Inc. 384

11.15.1 Company Overview 384

11.15.2 Revenue Analysis 384

11.15.3 Product Portfolio 385

11.15.4 Recent Developments 385

11.16 Skye Biologics Inc. 386

11.16.1 Company Overview 386

11.16.2 Product Portfolio : 386

11.16.3 Recent Development: 387

11.17 Smith And Nephew 388

11.17.1 Company Overview 388

11.17.2 Revenue Analysis 388

11.17.3 Product Portfolio 389

11.17.4 Recent Developments 389

11.18 Solsys Medical. 390

11.18.1 Company Overview 390

11.18.2 Product Portfolio 391

11.18.3 Recent Developments 391

11.19 Vericel Corporation. 392

11.19.1 Company Overview 392

11.19.2 1.1.2 Revenue Analysis 392

11.19.3 Product Portfolio 393

11.19.4 Recent Developments 393

11.20 Wright Medical Group N.V 394

11.20.1 Company Overview 394

11.20.2 1.1.2 Revenue Analysis 394

11.20.3 Product Portfolio 395

11.20.4 Recent Developments 396

12 Related Reports 397

?


List Of Figure

List Of Figures

Figure 1 Global Wound Care Biologics Market: Segmentation 35

Figure 2 Global Wound Care Biologics Market: Data Triangulation 38

Figure 3 Global Wound Care Biologics Market: Research Snapshot 39

Figure 4 Global Wound Care Biologics Market: Bottom Up Approach 40

Figure 5 Global Wound Care Biologics Market: Top Down Approach 40

Figure 6 Global Wound Care Biologics Market: Interview Demographics 41

Figure 1 Global Wound Care Biologics Market: Dbmr Market Position Grid 42

Figure 2 Global Wound Care Biologics Market: The Market Challenge Matrix 43

Figure 3 Drivers, Restraints, Opportunities And Challenges Of Global Wound Care Biologics Market 46

Figure 4 Aging Population In Different Countries (2014, 2017 & 2020) 49

Figure 5 Global Wound Care Biologics Market: Segmentation 58

Figure 6 North America Is Anticipated To Dominate The Global Wound Care Biologics Market And Asia Pacific Is Estimated To Be Increasing With The Strong Cagr In The Forecast Period From 2018 To 2025 59

Figure 7 Increasing Prevelance Of Diabetic Foot Ulcers And Increasing Incidences Of Burn Cases Are Expected To Drive The Market For Global Wound Care Biologics In The Forecast Period 2018 To 2025 60

Figure 8 Synthetic Skin Grafts In Global Wound Care Biologics Is Expected To Account For The Largest Share Of The Global Wound Care Biologics Market In 2018 & 2025 61

Figure 9 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Global Wound Care Biologics Market In The Forecast Period From 2018 To 2025 62

Figure 10 Worldwide Prevalence Of Various Wound Types, 2011 63

Figure 11 Cases Of Burn Injuries, (2009-2012) 63

Figure 12 Prevalence Of Pressure Ulcers In Few Countries 64

Figure 13 Number Of Surgical Procedures And Surgical Site Infections 64

Figure 14 Global Wound Care Biologics Market: By Product Type, 2017 66

Figure 15 Global Wound Care Biologics Market: By Wound Type, 2017 79

Figure 16 Global Wound Care Biologics Market: By End User, Snapshot 2017 99

Figure 17 Global Wound Care Biologics Market: Snapshot (2017) 108

Figure 18 Global Wound Care Biologics Market: By Country (2017) 109

Figure 19 Global Wound Care Biologics Market: By Country (2018 & 2025) 110

Figure 20 Global Wound Care Biologics Market, By Country (2017 & 2025) 111

Figure 21 Global Wound Care Biologics Market, By Product Type (2018 -2025) 112

Figure 22 North America Wound Care Biologics Market: Snapshot (2017) 114

Figure 23 North America Wound Care Biologics Market: By Country (2017) 115

Figure 24 North America Wound Care Biologics Market: By Country (2018 & 2025) 115

Figure 25 North America Wound Care Biologics Market, By Country (2017 & 2025) 116

Figure 26 North America Wound Care Biologics Market, By Product Type (2018 -2025) 117

Figure 27 Europe Wound Care Biologics Market: Snapshot (2017) 146

Figure 28 Europe Wound Care Biologics Market: By Country (2017) 147

Figure 29 Europe Wound Care Biologics Market: By Country (2018 & 2025) 148

Figure 30 Europe Wound Care Biologics Market, By Country (2017 & 2025) 149

Figure 31 Europe Wound Care Biologics Market, By Product Type (2018 -2025) 150

Figure 32 Asia-Pacific Wound Care Biologics Market: Snapshot (2017) 230

Figure 33 Asia-Pacific Wound Care Biologics Market: By Country (2017) 231

Figure 34 Asia-Pacific Wound Care Biologics Market: By Country (2018 & 2025) 232

Figure 35 Asia-Pacific Wound Care Biologics Market, By Country (2017 & 2025) 233

Figure 36 Asia-Pacific Wound Care Biologics Market, By Product Type (2018 -2025) 234

Figure 37 South America Wound Care Biologics Market: Snapshot (2017) 313

Figure 38 South America Wound Care Biologics Market: By Country (2017) 314

Figure 39 South America Wound Care Biologics Market: By Country (2018 & 2025) 314

Figure 40 South America Wound Care Biologics Market, By Country (2017 & 2025) 315

Figure 41 South America Wound Care Biologics Market, By Product Type (2018 -2025) 316

Figure 42 Middle East & Africa Wound Care Biologics Market: Snapshot (2017) 332

Figure 43 Middle East & Africa Wound Care Biologics Market: By Country (2017) 333

Figure 44 Middle East & Africa Wound Care Biologics Market: By Country (2018 & 2025) 333

Figure 45 Middle East & Africa Wound Care Biologics Market, By Country (2017 & 2025) 334

Figure 46 Middle East & Africa Wound Care Biologics Market, By Product Type (2018 -2025) 335

Figure 47 Global Wound Care Biologics Market: Company Share 2017 (%) 351

Figure 48 North America Wound Care Biologics Market: Company Share 2017 (%) 352

Figure 49 Europe Wound Care Biologics Market: Company Share 2017 (%) 353

Figure 50 Asia-Pacific Wound Care Biologics Market: Company Share 2017 (%) 354


List Of Table

Too Lengthy To Be Pasted

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

MiMedx

Organogenesis Inc.

Integra LifeSciences

ConvaTec Inc.

Smith and Nephew

INTEGRA LIFE SCIENCES CORPORATION

Molnlycke Health Care AB

chat_bubbleLet's Chat